Squarepoint
LABD icon

Squarepoint’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Squarepoint’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,490
Closed -$616K – 5042
2024
Q4 		$616K Buy
+8,490
New +$519K ﹤0.01% 3544

Other funds holding LABD

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
CCM
Capstone Capital Management Hong Kong $224M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Squarepoint's LABD Position: Q1 2026 in Review

Squarepoint opened a new position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2026: 65,713 shares worth $1.07M. The stake represents ﹤0.01% of the portfolio and ranks #2721 among its holdings. This is a return to the name: Squarepoint previously reported a position in LABD as recently as Q3 2024.

Squarepoint first reported a position in LABD in Q3 2021 and has held it in 6 quarters since. The position peaked at $1.65M in Q2 2022. 17 funds tracked by Wall St. Rank hold LABD as of Q1 2026.

  • Squarepoint held 65,713 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $1.07M as of Q1 2026.
  • Direxion Daily S&P Biotech Bear 3X ETF was a new Squarepoint position in Q1 2026.
  • Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2721 holding.
  • Squarepoint first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2021 and has held it in 6 quarters since.
  • Squarepoint's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $1.65M in Q2 2022.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.